You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

THIORIDAZINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for thioridazine hydrochloride and what is the scope of patent protection?

Thioridazine hydrochloride is the generic ingredient in three branded drugs marketed by Novartis, Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms, Epic Pharma Llc, Pharm Assoc, Sandoz, Wockhardt, Roxane, Chartwell Rx, Heritage Pharma Avet, Mutual Pharm, Mylan, Par Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in eighty NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for thioridazine hydrochloride. Three suppliers are listed for this compound.

Summary for THIORIDAZINE HYDROCHLORIDE
US Patents:0
Tradenames:3
Applicants:19
NDAs:80
Drug Master File Entries: 6
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 98
Clinical Trials: 10
Patent Applications: 5,277
What excipients (inactive ingredients) are in THIORIDAZINE HYDROCHLORIDE?THIORIDAZINE HYDROCHLORIDE excipients list
DailyMed Link:THIORIDAZINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for THIORIDAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rambam Health Care CampusEarly Phase 1
Rabin Medical CenterEarly Phase 1
Astellas Pharma IncPhase 4

See all THIORIDAZINE HYDROCHLORIDE clinical trials

Pharmacology for THIORIDAZINE HYDROCHLORIDE
Drug ClassPhenothiazine
Anatomical Therapeutic Chemical (ATC) Classes for THIORIDAZINE HYDROCHLORIDE

US Patents and Regulatory Information for THIORIDAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088755-001 Jul 24, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Superpharm THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 089104-001 Jul 2, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms THIORIDAZINE HYDROCHLORIDE thioridazine hydrochloride TABLET;ORAL 088493-001 May 17, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis MELLARIL thioridazine hydrochloride TABLET;ORAL 011808-017 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.